BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hutt-Fletcher LM. Epstein-Barr virus entry. J Virol 2007;81:7825-32. [PMID: 17459936 DOI: 10.1128/JVI.00445-07] [Cited by in Crossref: 174] [Cited by in F6Publishing: 126] [Article Influence: 11.6] [Reference Citation Analysis]
Number Citing Articles
1 Schultz EP, Lanchy JM, Day LZ, Yu Q, Peterson C, Preece J, Ryckman BJ. Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci. J Virol 2020;94:e00034-20. [PMID: 32321807 DOI: 10.1128/JVI.00034-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
2 Jiang L, Xie C, Lung HL, Lo KW, Law GL, Mak NK, Wong KL. EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers. Theranostics 2018;8:5307-19. [PMID: 30555548 DOI: 10.7150/thno.26823] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
3 Wu L, Li C, Pan L. Nasopharyngeal carcinoma: A review of current updates. Exp Ther Med 2018;15:3687-92. [PMID: 29556258 DOI: 10.3892/etm.2018.5878] [Cited by in Crossref: 13] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
4 Machiels B, Lété C, de Fays K, Mast J, Dewals B, Stevenson PG, Vanderplasschen A, Gillet L. The bovine herpesvirus 4 Bo10 gene encodes a nonessential viral envelope protein that regulates viral tropism through both positive and negative effects. J Virol 2011;85:1011-24. [PMID: 21068242 DOI: 10.1128/JVI.01092-10] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
5 Griffiths PD. HCMV gets a Sat-Nav too. Rev Med Virol 2011;21:137-8. [PMID: 21538663 DOI: 10.1002/rmv.693] [Reference Citation Analysis]
6 Ciccocioppo R, Racca F, Scudeller L, Piralla A, Formagnana P, Pozzi L, Betti E, Vanoli A, Riboni R, Kruzliak P, Baldanti F, Corazza GR. Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease. Immunol Res 2016;64:191-203. [PMID: 26659090 DOI: 10.1007/s12026-015-8737-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
7 Márquez AC, Horwitz MS. The Role of Latently Infected B Cells in CNS Autoimmunity. Front Immunol 2015;6:544. [PMID: 26579121 DOI: 10.3389/fimmu.2015.00544] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
8 Zhu QY, Zhao GX, Li Y, Talakatta G, Mai HQ, Le QT, Young LS, Zeng MS. Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma. MedComm (2020) 2021;2:175-206. [PMID: 34766141 DOI: 10.1002/mco2.32] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liu H, Gemmell L, Lin R, Zuo F, Balfour HH Jr, Woo JC, Hayes GM. Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine. Mediterr J Hematol Infect Dis 2020;12:e2020016. [PMID: 32180911 DOI: 10.4084/MJHID.2020.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Cui X, Snapper CM. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Front Immunol 2021;12:734471. [PMID: 34691042 DOI: 10.3389/fimmu.2021.734471] [Reference Citation Analysis]
11 Wu Y, Wei F, Tang L, Liao Q, Wang H, Shi L, Gong Z, Zhang W, Zhou M, Xiang B, Wu X, Li X, Li Y, Li G, Xiong W, Zeng Z, Xiong F, Guo C. Herpesvirus acts with the cytoskeleton and promotes cancer progression. J Cancer 2019;10:2185-93. [PMID: 31258722 DOI: 10.7150/jca.30222] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
12 Li Q, Cohen JI. Epstein-Barr Virus and the Human Leukocyte Antigen Complex. Curr Clin Microbiol Rep 2019;6:175-81. [PMID: 33094090 DOI: 10.1007/s40588-019-00120-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Vanarsdall AL, Johnson DC. Human cytomegalovirus entry into cells. Curr Opin Virol. 2012;2:37-42. [PMID: 22440964 DOI: 10.1016/j.coviro.2012.01.001] [Cited by in Crossref: 95] [Cited by in F6Publishing: 88] [Article Influence: 9.5] [Reference Citation Analysis]
14 Chantre-justino M, Figueiredo MC, Alves G, Ornellas MHF. Prevalence of Epstein–Barr virus infection in recurrent respiratory papillomatosis and the influence on disease severity. Diagnostic Microbiology and Infectious Disease 2022. [DOI: 10.1016/j.diagmicrobio.2022.115655] [Reference Citation Analysis]
15 Machiels B, Stevenson PG, Vanderplasschen A, Gillet L. A gammaherpesvirus uses alternative splicing to regulate its tropism and its sensitivity to neutralization. PLoS Pathog 2013;9:e1003753. [PMID: 24204281 DOI: 10.1371/journal.ppat.1003753] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
16 Gillet L, Stevenson PG. Evidence for a multiprotein gamma-2 herpesvirus entry complex. J Virol 2007;81:13082-91. [PMID: 17898071 DOI: 10.1128/JVI.01141-07] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
17 Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Front Oncol. 2018;8:211. [PMID: 29951372 DOI: 10.3389/fonc.2018.00211] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 16.3] [Reference Citation Analysis]
18 Hutt-Fletcher LM. EBV glycoproteins: where are we now? Future Virol 2015;10:1155-62. [PMID: 26843889 DOI: 10.2217/fvl.15.80] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
19 Blanco R, Aguayo F. Role of BamHI-A Rightward Frame 1 in Epstein-Barr Virus-Associated Epithelial Malignancies. Biology (Basel) 2020;9:E461. [PMID: 33322292 DOI: 10.3390/biology9120461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Sorem J, Jardetzky TS, Longnecker R. Cleavage and secretion of Epstein-Barr virus glycoprotein 42 promote membrane fusion with B lymphocytes. J Virol 2009;83:6664-72. [PMID: 19369343 DOI: 10.1128/JVI.00195-09] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
21 Dollery SJ, Maldonado TD, Brenner EA, Berger EA. iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release. Front Cell Infect Microbiol 2021;11:654396. [PMID: 33937098 DOI: 10.3389/fcimb.2021.654396] [Reference Citation Analysis]
22 Shaw PL, Kirschner AN, Jardetzky TS, Longnecker R. Characteristics of Epstein-Barr virus envelope protein gp42. Virus Genes 2010;40:307-19. [PMID: 20162447 DOI: 10.1007/s11262-010-0455-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wagner FM, Brizic I, Prager A, Trsan T, Arapovic M, Lemmermann NA, Podlech J, Reddehase MJ, Lemnitzer F, Bosse JB, Gimpfl M, Marcinowski L, MacDonald M, Adler H, Koszinowski UH, Adler B. The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH/gL/MCK-2 complex. PLoS Pathog 2013;9:e1003493. [PMID: 23935483 DOI: 10.1371/journal.ppat.1003493] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
24 Genitsch V, Novotny A, Seiler CA, Kröll D, Walch A, Langer R. Epstein-barr virus in gastro-esophageal adenocarcinomas - single center experiences in the context of current literature. Front Oncol 2015;5:73. [PMID: 25859432 DOI: 10.3389/fonc.2015.00073] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
25 Li G, Kamil JP. Viral Regulation of Cell Tropism in Human Cytomegalovirus. J Virol 2016;90:626-9. [PMID: 26559829 DOI: 10.1128/JVI.01500-15] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
26 Zhou M, Yu Q, Wechsler A, Ryckman BJ. Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope. J Virol 2013;87:9680-90. [PMID: 23804643 DOI: 10.1128/JVI.01167-13] [Cited by in Crossref: 79] [Cited by in F6Publishing: 58] [Article Influence: 8.8] [Reference Citation Analysis]
27 Tugizov SM, Herrera R, Palefsky JM. Epstein-Barr virus transcytosis through polarized oral epithelial cells. J Virol. 2013;87:8179-8194. [PMID: 23698302 DOI: 10.1128/jvi.00443-13] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
28 Uehara K, Tanabe Y, Hirota S, Higa S, Toyoda Z, Kurima K, Kina S, Nakasone T, Arasaki A, Kinjo T. Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage. BMC Cancer 2021;21:688. [PMID: 34112111 DOI: 10.1186/s12885-021-08397-0] [Reference Citation Analysis]
29 Nowak SA, Chou T. Mechanisms of receptor/coreceptor-mediated entry of enveloped viruses. Biophys J 2009;96:2624-36. [PMID: 19348746 DOI: 10.1016/j.bpj.2009.01.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
30 Rani A, Jakhmola S, Karnati S, Parmar HS, Chandra Jha H. Potential entry receptors for human γ-herpesvirus into epithelial cells: A plausible therapeutic target for viral infections. Tumour Virus Res 2021;12:200227. [PMID: 34800753 DOI: 10.1016/j.tvr.2021.200227] [Reference Citation Analysis]
31 Dorner M, Zucol F, Berger C, Byland R, Melroe GT, Bernasconi M, Speck RF, Nadal D. Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to differentiation status and tissue origin. J Virol 2008;82:4400-12. [PMID: 18321980 DOI: 10.1128/JVI.02630-07] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
32 Scrivano L, Esterlechner J, Mühlbach H, Ettischer N, Hagen C, Grünewald K, Mohr CA, Ruzsics Z, Koszinowski U, Adler B. The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. J Virol 2010;84:4469-80. [PMID: 20181688 DOI: 10.1128/JVI.02441-09] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
33 Glauser DL, Kratz AS, Gillet L, Stevenson PG. A mechanistic basis for potent, glycoprotein B-directed gammaherpesvirus neutralization. J Gen Virol 2011;92:2020-33. [PMID: 21593277 DOI: 10.1099/vir.0.032177-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ryckman BJ, Rainish BL, Chase MC, Borton JA, Nelson JA, Jarvis MA, Johnson DC. Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol 2008;82:60-70. [PMID: 17942555 DOI: 10.1128/JVI.01910-07] [Cited by in Crossref: 239] [Cited by in F6Publishing: 170] [Article Influence: 15.9] [Reference Citation Analysis]
35 Ni C, Chen Y, Zeng M, Pei R, Du Y, Tang L, Wang M, Hu Y, Zhu H, He M, Wei X, Wang S, Ning X, Wang M, Wang J, Ma L, Chen X, Sun Q, Tang H, Wang Y, Wang X. In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures. Cell Res 2015;25:785-800. [PMID: 25916549 DOI: 10.1038/cr.2015.50] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
36 Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, He JY, Li MZ, Liu YM, Zhou AJ, Zhong Q, Zeng YX, Kieff E, Zhang Z, Gewurz BE, Zhao B, Zeng MS. Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nat Microbiol 2018;3:1-8. [PMID: 29292383 DOI: 10.1038/s41564-017-0080-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 78] [Article Influence: 14.5] [Reference Citation Analysis]
37 Hatano Y, Ideta T, Hirata A, Hatano K, Tomita H, Okada H, Shimizu M, Tanaka T, Hara A. Virus-Driven Carcinogenesis. Cancers (Basel) 2021;13:2625. [PMID: 34071792 DOI: 10.3390/cancers13112625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Kanekiyo M, Bu W, Joyce MG, Meng G, Whittle JR, Baxa U, Yamamoto T, Narpala S, Todd JP, Rao SS, McDermott AB, Koup RA, Rossmann MG, Mascola JR, Graham BS, Cohen JI, Nabel GJ. Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site. Cell 2015;162:1090-100. [PMID: 26279189 DOI: 10.1016/j.cell.2015.07.043] [Cited by in Crossref: 149] [Cited by in F6Publishing: 130] [Article Influence: 21.3] [Reference Citation Analysis]
39 Wright CC, Wisner TW, Hannah BP, Eisenberg RJ, Cohen GH, Johnson DC. Fusion between perinuclear virions and the outer nuclear membrane requires the fusogenic activity of herpes simplex virus gB. J Virol 2009;83:11847-56. [PMID: 19759132 DOI: 10.1128/JVI.01397-09] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
40 Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM; NeuroproMiSe EBV Working Group. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011;134:2772-86. [PMID: 21846731 DOI: 10.1093/brain/awr197] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 11.0] [Reference Citation Analysis]
41 Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 2009;5:e1000496. [PMID: 19578433 DOI: 10.1371/journal.ppat.1000496] [Cited by in Crossref: 157] [Cited by in F6Publishing: 146] [Article Influence: 12.1] [Reference Citation Analysis]
42 Brooks JM, Long HM, Tierney RJ, Shannon-Lowe C, Leese AM, Fitzpatrick M, Taylor GS, Rickinson AB. Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination. PLoS Pathog 2016;12:e1005549. [PMID: 27096949 DOI: 10.1371/journal.ppat.1005549] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
43 Griffiths PD. Sat-Nav virology. Rev Med Virol 2008;18:291-2. [PMID: 18702084 DOI: 10.1002/rmv.594] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Jiang R, Ekshyyan O, Moore-Medlin T, Rong X, Nathan S, Gu X, Abreo F, Rosenthal EL, Shi M, Guidry JT, Scott RS, Hutt-Fletcher LM, Nathan CA. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis. J Oral Pathol Med 2015;44:28-36. [PMID: 25040496 DOI: 10.1111/jop.12221] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
45 Zhang W, Gao SJ. Exploitation of Cellular Cytoskeletons and Signaling Pathways for Cell Entry by Kaposi's Sarcoma-Associated Herpesvirus and the Closely Related Rhesus Rhadinovirus. Pathogens 2012;1:102-27. [PMID: 23420076 DOI: 10.3390/pathogens1020102] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
46 Chesnokova LS, Hutt-Fletcher LM. Epstein-Barr virus infection mechanisms. Chin J Cancer 2014;33:545-8. [PMID: 25322867 DOI: 10.5732/cjc.014.10168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
47 Chesnokova LS, Nishimura SL, Hutt-Fletcher LM. Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8. Proc Natl Acad Sci U S A 2009;106:20464-9. [PMID: 19920174 DOI: 10.1073/pnas.0907508106] [Cited by in Crossref: 131] [Cited by in F6Publishing: 125] [Article Influence: 10.1] [Reference Citation Analysis]
48 Zhang W, Zhou F, Greene W, Gao SJ. Rhesus rhadinovirus infection of rhesus fibroblasts occurs through clathrin-mediated endocytosis. J Virol 2010;84:11709-17. [PMID: 20826690 DOI: 10.1128/JVI.01429-10] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
49 Xiong D, Du Y, Wang HB, Zhao B, Zhang H, Li Y, Hu LJ, Cao JY, Zhong Q, Liu WL, Li MZ, Zhu XF, Tsao SW, Hutt-Fletcher LM, Song E, Zeng YX, Kieff E, Zeng MS. Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells. Proc Natl Acad Sci U S A 2015;112:11036-41. [PMID: 26290577 DOI: 10.1073/pnas.1513359112] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
50 Lyman MG, Enquist LW. Herpesvirus interactions with the host cytoskeleton. J Virol 2009;83:2058-66. [PMID: 18842724 DOI: 10.1128/JVI.01718-08] [Cited by in Crossref: 99] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
51 Li S, Lu Z, Yao M, Ning S, Wu Y, Zhou X, Zhong C, Yan K, Xie Y, Wei Z. Association of Single-Nucleotide Polymorphisms in DC-SIGN with Nasopharyngeal Carcinoma Susceptibility. Dis Markers 2017;2017:6309754. [PMID: 28694559 DOI: 10.1155/2017/6309754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
52 Dorner M, Zucol F, Alessi D, Haerle SK, Bossart W, Weber M, Byland R, Bernasconi M, Berger C, Tugizov S, Speck RF, Nadal D. beta1 integrin expression increases susceptibility of memory B cells to Epstein-Barr virus infection. J Virol 2010;84:6667-77. [PMID: 20427540 DOI: 10.1128/JVI.02675-09] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
53 Ning S, Yao M, Wu Y, Zhou X, Zhong C, Yan K, Wei Z, Xie Y. Correlation of variable repeat number in the neck regions of DC-SIGN and DC-SIGNR with susceptibility to nasopharyngeal carcinoma in a Chinese population. Cancer Manag Res 2018;10:3193-8. [PMID: 30233235 DOI: 10.2147/CMAR.S167114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Boussamet L, Montassier E, Soulillou JP, Berthelot L. Anti α1-3Gal antibodies and Gal content in gut microbiota in immune disorders and multiple sclerosis. Clin Immunol 2021;:108693. [PMID: 33556564 DOI: 10.1016/j.clim.2021.108693] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Busse C, Feederle R, Schnölzer M, Behrends U, Mautner J, Delecluse HJ. Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding. J Virol 2010;84:1139-47. [PMID: 19889766 DOI: 10.1128/JVI.01953-09] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
56 Hutt-Fletcher LM. The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells. J Virol 2017;91:e01677-16. [PMID: 27795426 DOI: 10.1128/JVI.01677-16] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
57 Crepeau RL, Elengickal JA, La Muraglia GM 2nd, Ford ML. Impact of selective CD28 blockade on virus-specific immunity to a murine Epstein-Barr virus homolog. Am J Transplant 2019;19:2199-209. [PMID: 30801917 DOI: 10.1111/ajt.15321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Zhao B, Zhang X, Krummenacher C, Song S, Gao L, Zhang H, Xu M, Feng L, Feng Q, Zeng M, Xu Y, Zeng Y. Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model. Front Immunol 2018;9:932. [PMID: 29765376 DOI: 10.3389/fimmu.2018.00932] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
59 Kikuchi K, Inoue H, Miyazaki Y, Ide F, Kojima M, Kusama K. Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity. Jpn Dent Sci Rev. 2017;53:95-109. [PMID: 28725300 DOI: 10.1016/j.jdsr.2017.01.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
60 Tang H, Hayashi M, Maeki T, Yamanishi K, Mori Y. Human herpesvirus 6 glycoprotein complex formation is required for folding and trafficking of the gH/gL/gQ1/gQ2 complex and its cellular receptor binding. J Virol 2011;85:11121-30. [PMID: 21849437 DOI: 10.1128/JVI.05251-11] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
61 Kerur N, Veettil MV, Sharma-Walia N, Sadagopan S, Bottero V, Paul AG, Chandran B. Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling. Virology 2010;406:103-16. [PMID: 20674951 DOI: 10.1016/j.virol.2010.07.012] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
62 Frederico B, Milho R, May JS, Gillet L, Stevenson PG. Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4. PLoS Pathog 2012;8:e1002935. [PMID: 23028329 DOI: 10.1371/journal.ppat.1002935] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
63 Valencia SM, Hutt-Fletcher LM. Important but differential roles for actin in trafficking of Epstein-Barr virus in B cells and epithelial cells. J Virol 2012;86:2-10. [PMID: 22031939 DOI: 10.1128/JVI.05883-11] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
64 Ryckman BJ, Chase MC, Johnson DC. HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc Natl Acad Sci U S A. 2008;105:14118-14123. [PMID: 18768787 DOI: 10.1073/pnas.0804365105] [Cited by in Crossref: 134] [Cited by in F6Publishing: 129] [Article Influence: 9.6] [Reference Citation Analysis]
65 Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol 2011;9:369-81. [PMID: 21478902 DOI: 10.1038/nrmicro2548] [Cited by in Crossref: 305] [Cited by in F6Publishing: 282] [Article Influence: 27.7] [Reference Citation Analysis]
66 Fierti AO, Yakass MB, Okertchiri EA, Adadey SM, Quaye O. The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications. Biomolecules 2022;12:127. [DOI: 10.3390/biom12010127] [Reference Citation Analysis]
67 Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD. Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor. Cell Rep. 2013;3:371-385. [PMID: 23416052 DOI: 10.1016/j.celrep.2013.01.023] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 8.7] [Reference Citation Analysis]
68 Chappell DL, White MC, Damania B. Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis. Adv Virus Res 2021;109:201-54. [PMID: 33934828 DOI: 10.1016/bs.aivir.2020.10.001] [Reference Citation Analysis]
69 Connolly SA, Jardetzky TS, Longnecker R. The structural basis of herpesvirus entry. Nat Rev Microbiol 2021;19:110-21. [PMID: 33087881 DOI: 10.1038/s41579-020-00448-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
70 Arredouani MS, Bhasin MK, Sage DR, Dunn LK, Gill MB, Agnani D, Libermann TA, Fingeroth JD. Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection. J Virol 2014;88:5559-77. [PMID: 24600013 DOI: 10.1128/JVI.03099-13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
71 Van de Walle GR, Peters ST, VanderVen BC, O'Callaghan DJ, Osterrieder N. Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D. J Virol 2008;82:11859-68. [PMID: 18815313 DOI: 10.1128/JVI.00868-08] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
72 Gerna G, Kabanova A, Lilleri D. Human Cytomegalovirus Cell Tropism and Host Cell Receptors. Vaccines (Basel) 2019;7:E70. [PMID: 31336680 DOI: 10.3390/vaccines7030070] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
73 Reimer JJ, Backovic M, Deshpande CG, Jardetzky T, Longnecker R. Analysis of Epstein-Barr virus glycoprotein B functional domains via linker insertion mutagenesis. J Virol 2009;83:734-47. [PMID: 18987135 DOI: 10.1128/JVI.01817-08] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
74 Gallo A, Jang SI, Ong HL, Perez P, Tandon M, Ambudkar I, Illei G, Alevizos I. Targeting the Ca(2+) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome. EBioMedicine 2016;10:216-26. [PMID: 27381477 DOI: 10.1016/j.ebiom.2016.06.041] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
75 Tonoyan L, Vincent-Bugnas S, Olivieri CV, Doglio A. New Viral Facets in Oral Diseases: The EBV Paradox. Int J Mol Sci 2019;20:E5861. [PMID: 31766729 DOI: 10.3390/ijms20235861] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
76 Adler B. A Viral Pilot for HCMV Navigation? Viruses 2015;7:3857-62. [PMID: 26184287 DOI: 10.3390/v7072801] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
77 Chesnokova LS, Hutt-Fletcher LM. Fusion of Epstein-Barr virus with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8, and integrin binding triggers a conformational change in glycoproteins gHgL. J Virol 2011;85:13214-23. [PMID: 21957301 DOI: 10.1128/JVI.05580-11] [Cited by in Crossref: 80] [Cited by in F6Publishing: 62] [Article Influence: 7.3] [Reference Citation Analysis]
78 Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol 2015;235:323-33. [PMID: 25251730 DOI: 10.1002/path.4448] [Cited by in Crossref: 173] [Cited by in F6Publishing: 155] [Article Influence: 24.7] [Reference Citation Analysis]
79 Osorio JC, Blanco R, Corvalán AH, Muñoz JP, Calaf GM, Aguayo F. Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives. Pathogens 2022;11:132. [DOI: 10.3390/pathogens11020132] [Reference Citation Analysis]
80 Singh S, Jha HC. Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer. J Oncol 2017;2017:3456264. [PMID: 28421114 DOI: 10.1155/2017/3456264] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
81 Wang HB, Zhang H, Zhang JP, Li Y, Zhao B, Feng GK, Du Y, Xiong D, Zhong Q, Liu WL, Du H, Li MZ, Huang WL, Tsao SW, Hutt-Fletcher L, Zeng YX, Kieff E, Zeng MS. Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells. Nat Commun 2015;6:6240. [PMID: 25670642 DOI: 10.1038/ncomms7240] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 10.7] [Reference Citation Analysis]
82 Houldcroft CJ, Kellam P. Host genetics of Epstein-Barr virus infection, latency and disease. Rev Med Virol. 2015;25:71-84. [PMID: 25430668 DOI: 10.1002/rmv.1816] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
83 Lehmann-Horn K, Kinzel S, Weber MS. Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function. Int J Mol Sci 2017;18:E2048. [PMID: 28946620 DOI: 10.3390/ijms18102048] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
84 Goon P, Schürmann M, Oppel F, Shao S, Schleyer S, Pfeiffer CJ, Todt I, Brasch F, Scholtz L, Göerner M, Sudhoff H. Viral and Clinical Oncology of Head and Neck Cancers. Curr Oncol Rep. [DOI: 10.1007/s11912-022-01263-7] [Reference Citation Analysis]
85 Sathiyamoorthy K, Jiang J, Hu YX, Rowe CL, Möhl BS, Chen J, Jiang W, Mellins ED, Longnecker R, Zhou ZH, Jardetzky TS. Assembly and architecture of the EBV B cell entry triggering complex. PLoS Pathog 2014;10:e1004309. [PMID: 25144748 DOI: 10.1371/journal.ppat.1004309] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
86 Germini D, Sall FB, Shmakova A, Wiels J, Dokudovskaya S, Drouet E, Vassetzky Y. Oncogenic Properties of the EBV ZEBRA Protein. Cancers (Basel) 2020;12:E1479. [PMID: 32517128 DOI: 10.3390/cancers12061479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
87 Young KA, Herbert AP, Barlow PN, Holers VM, Hannan JP. Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350. J Virol 2008;82:11217-27. [PMID: 18786993 DOI: 10.1128/JVI.01673-08] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
88 Wille PT, Knoche AJ, Nelson JA, Jarvis MA, Johnson DC. A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J Virol 2010;84:2585-96. [PMID: 20032184 DOI: 10.1128/JVI.02249-09] [Cited by in Crossref: 112] [Cited by in F6Publishing: 90] [Article Influence: 8.6] [Reference Citation Analysis]
89 Zhang D, Broyles D, Hunt EA, Dikici E, Daunert S, Deo SK. A paper-based platform for detection of viral RNA. Analyst 2017;142:815-23. [PMID: 28194453 DOI: 10.1039/c6an02452a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
90 Myoung J, Ganem D. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 2011;174:12-21. [PMID: 21419799 DOI: 10.1016/j.jviromet.2011.03.012] [Cited by in Crossref: 204] [Cited by in F6Publishing: 184] [Article Influence: 18.5] [Reference Citation Analysis]
91 Neuhierl B, Feederle R, Adhikary D, Hub B, Geletneky K, Mautner J, Delecluse HJ. Primary B-cell infection with a deltaBALF4 Epstein-Barr virus comes to a halt in the endosomal compartment yet still elicits a potent CD4-positive cytotoxic T-cell response. J Virol 2009;83:4616-23. [PMID: 19244320 DOI: 10.1128/JVI.01613-08] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
92 Mansouri S, Wang S, Frappier L. A role for the nucleosome assembly proteins TAF-Iβ and NAP1 in the activation of BZLF1 expression and Epstein-Barr virus reactivation. PLoS One 2013;8:e63802. [PMID: 23691099 DOI: 10.1371/journal.pone.0063802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
93 Ye X, Gui X, Freed DC, Ku Z, Li L, Chen Y, Xiong W, Fan X, Su H, He X, Rustandi RR, Loughney JW, Ma N, Espeseth AS, Liu J, Zhu H, Wang D, Zhang N, Fu TM, An Z. Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection. PLoS Pathog 2019;15:e1007914. [PMID: 31356650 DOI: 10.1371/journal.ppat.1007914] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
94 Xuan J, Ji Z, Wang B, Zeng X, Chen R, He Y, Rao P, Wu P, Shi G. Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren's Syndrome. Front Immunol 2020;11:590444. [PMID: 33193425 DOI: 10.3389/fimmu.2020.590444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells. Virology 2008;370:430-42. [PMID: 17945327 DOI: 10.1016/j.virol.2007.09.012] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
96 Chen J, Rowe CL, Jardetzky TS, Longnecker R. The KGD motif of Epstein-Barr virus gH/gL is bifunctional, orchestrating infection of B cells and epithelial cells. mBio 2012;3:e00290-11. [PMID: 22215569 DOI: 10.1128/mBio.00290-11] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
97 Takahara M, Kumai T, Kishibe K, Nagato T, Harabuchi Y. Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein-Barr Virus Relation. Microorganisms 2021;9:1381. [PMID: 34202088 DOI: 10.3390/microorganisms9071381] [Reference Citation Analysis]
98 Garry CE, Garry RF. Proteomics computational analyses suggest that baculovirus GP64 superfamily proteins are class III penetrenes. Virol J 2008;5:28. [PMID: 18282283 DOI: 10.1186/1743-422X-5-28] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
99 Ryckman BJ, Chase MC, Johnson DC. Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J Virol. 2010;84:2597-2609. [PMID: 20032193 DOI: 10.1128/JVI.02256-09] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
100 Meier UC, Giovannoni G, Tzartos JS, Khan G. Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system? Clin Exp Immunol 2012;167:1-6. [PMID: 22132878 DOI: 10.1111/j.1365-2249.2011.04446.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
101 Changotra H, Turk SM, Artigues A, Thakur N, Gore M, Muggeridge MI, Hutt-Fletcher LM. Epstein-Barr virus glycoprotein gM can interact with the cellular protein p32 and knockdown of p32 impairs virus. Virology 2016;489:223-32. [PMID: 26773383 DOI: 10.1016/j.virol.2015.12.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
102 Maeki T, Mori Y. Features of Human Herpesvirus-6A and -6B Entry. Adv Virol 2012;2012:384069. [PMID: 23133452 DOI: 10.1155/2012/384069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
103 Feng D, Cui M, Jia R, Liu S, Wang M, Zhu D, Chen S, Liu M, Zhao X, Wu Y, Yang Q, Yin Z, Cheng A. Co-localization of and interaction between duck enteritis virus glycoprotein H and L. BMC Vet Res 2018;14:255. [PMID: 30157854 DOI: 10.1186/s12917-018-1553-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
104 Sorem J, Longnecker R. Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells. J Gen Virol 2009;90:591-5. [PMID: 19218203 DOI: 10.1099/vir.0.007237-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
105 Knerr JM, Kledal TN, Rosenkilde MM. Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1. Cancers (Basel) 2021;13:4079. [PMID: 34439235 DOI: 10.3390/cancers13164079] [Reference Citation Analysis]
106 Jiang R, Gu X, Nathan CO, Hutt-Fletcher L. Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells. J Oral Pathol Med 2008;37:626-33. [PMID: 18710421 DOI: 10.1111/j.1600-0714.2008.00681.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
107 Nanbo A, Terada H, Kachi K, Takada K, Matsuda T. Roles of cell signaling pathways in cell-to-cell contact-mediated Epstein-Barr virus transmission. J Virol 2012;86:9285-96. [PMID: 22718812 DOI: 10.1128/JVI.00712-12] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
108 Sangueza-Acosta M, Sandoval-Romero E. Epstein-Barr virus and skin. An Bras Dermatol 2018;93:786-99. [PMID: 30484521 DOI: 10.1590/abd1806-4841.20187021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
109 Vanarsdall AL, Chase MC, Johnson DC. Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells. J Virol 2011;85:11638-45. [PMID: 21880752 DOI: 10.1128/JVI.05659-11] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
110 Machiels B, Lété C, Guillaume A, Mast J, Stevenson PG, Vanderplasschen A, Gillet L. Antibody evasion by a gammaherpesvirus O-glycan shield. PLoS Pathog 2011;7:e1002387. [PMID: 22114560 DOI: 10.1371/journal.ppat.1002387] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
111 Lawler C, de Miranda MP, May J, Wyer O, Simas JP, Stevenson PG. Gammaherpesvirus Colonization of the Spleen Requires Lytic Replication in B Cells. J Virol 2018;92:e02199-17. [PMID: 29343572 DOI: 10.1128/JVI.02199-17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
112 Chen H, Zhang X, Zhang S, Duan X, Xiang T, Zhou X, Zhang W, Zhang X, Feng Q, Kang Y, Li J, Deng L, Wang L, Lv X, Zeng M, Zeng YX, Xu M. T cell epitope screening of Epstein-Barr virus fusion protein gB. J Virol 2021:JVI. [PMID: 33658348 DOI: 10.1128/JVI.00081-21] [Reference Citation Analysis]
113 Schäfer G, Blumenthal MJ, Katz AA. Interaction of human tumor viruses with host cell surface receptors and cell entry. Viruses 2015;7:2592-617. [PMID: 26008702 DOI: 10.3390/v7052592] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
114 Milho R, Gill MB, May JS, Colaco S, Stevenson PG. In vivo function of the murid herpesvirus-4 ribonucleotide reductase small subunit. J Gen Virol 2011;92:1550-60. [PMID: 21471322 DOI: 10.1099/vir.0.031542-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
115 Zhu J, Liao G, Shan L, Zhang J, Chen MR, Hayward GS, Hayward SD, Desai P, Zhu H. Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4. J Virol 2009;83:5219-31. [PMID: 19244323 DOI: 10.1128/JVI.02378-08] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
116 Hosoi H, Mushino T, Nakashima K, Kuriyama K, Tamura S, Murata S, Imadome KI, Ohshima K, Sonoki T. Composite Epstein-Barr Virus-associated T-lymphoblastic and Peripheral T-cell Lymphomas: A Clonal Study. Intern Med 2021;60:2119-23. [PMID: 33551410 DOI: 10.2169/internalmedicine.6572-20] [Reference Citation Analysis]
117 Li Q, Bu W, Gabriel E, Aguilar F, Hoshino Y, Miyadera H, Hess C, Hornung RL, Roy A, Cohen JI. HLA-DQ β1 alleles associated with Epstein-Barr virus (EBV) infectivity and EBV gp42 binding to cells. JCI Insight 2017;2:e85687. [PMID: 28239644 DOI: 10.1172/jci.insight.85687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
118 Miles JJ, Bulek AM, Cole DK, Gostick E, Schauenburg AJ, Dolton G, Venturi V, Davenport MP, Tan MP, Burrows SR, Wooldridge L, Price DA, Rizkallah PJ, Sewell AK. Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection. PLoS Pathog 2010;6:e1001198. [PMID: 21124993 DOI: 10.1371/journal.ppat.1001198] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
119 Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol 2015;390:211-40. [PMID: 26424648 DOI: 10.1007/978-3-319-22822-8_9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
120 Su T, Chapin SJ, Bryant DM, Shewan AM, Young K, Mostov KE. Reduced immunoglobulin A transcytosis associated with immunoglobulin A nephropathy and nasopharyngeal carcinoma. J Biol Chem 2011;286:44921-5. [PMID: 22086919 DOI: 10.1074/jbc.M111.296731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
121 Wu TT, Blackman MA, Sun R. Prospects of a novel vaccination strategy for human gamma-herpesviruses. Immunol Res 2010;48:122-46. [PMID: 20717741 DOI: 10.1007/s12026-010-8172-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
122 Chesnokova LS, Valencia SM, Hutt-Fletcher LM. The BDLF3 gene product of Epstein-Barr virus, gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection. Virology 2016;494:23-8. [PMID: 27061054 DOI: 10.1016/j.virol.2016.04.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
123 Cui X, Cao Z, Ishikawa Y, Cui S, Imadome KI, Snapper CM. Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge. Vaccines (Basel) 2021;9:285. [PMID: 33808755 DOI: 10.3390/vaccines9030285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Kwok H, Wu CW, Palser AL, Kellam P, Sham PC, Kwong DL, Chiang AK. Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. J Virol 2014;88:10662-72. [PMID: 24991008 DOI: 10.1128/JVI.01665-14] [Cited by in Crossref: 74] [Cited by in F6Publishing: 42] [Article Influence: 9.3] [Reference Citation Analysis]
125 Liu F, Marquardt G, Kirschner AN, Longnecker R, Jardetzky TS. Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using fluorescence polarization and cell-based fusion assays. J Virol 2010;84:10375-85. [PMID: 20668073 DOI: 10.1128/JVI.00381-10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
126 Png YT, Yang AZY, Lee MY, Chua MJM, Lim CM. The Role of NK Cells in EBV Infection and EBV-Associated NPC. Viruses 2021;13:300. [PMID: 33671917 DOI: 10.3390/v13020300] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
127 Wang L, Laing J, Yan B, Zhou H, Ke L, Wang C, Narita Y, Zhang Z, Olson MR, Afzali B, Zhao B, Kazemian M. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells. J Virol 2020;94:e01390-20. [PMID: 32999023 DOI: 10.1128/JVI.01390-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
128 Wortman MJ, Lundberg PS, Dagdanova AV, Venkataraman P, Daniel DC, Johnson EM. Opportunistic DNA Recombination With Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence. J Infect Dis 2016;213:1436-43. [PMID: 26690342 DOI: 10.1093/infdis/jiv755] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
129 Barros MHM, Vera-Lozada G, Segges P, Hassan R, Niedobitek G. Revisiting the Tissue Microenvironment of Infectious Mononucleosis: Identification of EBV Infection in T Cells and Deep Characterization of Immune Profiles. Front Immunol 2019;10:146. [PMID: 30842768 DOI: 10.3389/fimmu.2019.00146] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
130 Scrivano L, Sinzger C, Nitschko H, Koszinowski UH, Adler B. HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog 2011;7:e1001256. [PMID: 21249233 DOI: 10.1371/journal.ppat.1001256] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 9.4] [Reference Citation Analysis]
131 Berarducci B, Rajamani J, Zerboni L, Che X, Sommer M, Arvin AM. Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection. Proc Natl Acad Sci U S A 2010;107:282-7. [PMID: 19966293 DOI: 10.1073/pnas.0912373107] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
132 Richardo T, Prattapong P, Ngernsombat C, Wisetyaningsih N, Iizasa H, Yoshiyama H, Janvilisri T. Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis. Cancers (Basel) 2020;12:E2441. [PMID: 32872147 DOI: 10.3390/cancers12092441] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
133 Lemmermann NA, Krmpotic A, Podlech J, Brizic I, Prager A, Adler H, Karbach A, Wu Y, Jonjic S, Reddehase MJ, Adler B. Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spread. PLoS Pathog 2015;11:e1004640. [PMID: 25659098 DOI: 10.1371/journal.ppat.1004640] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
134 Dunmire SK, Grimm JM, Schmeling DO, Balfour HH Jr, Hogquist KA. The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events. PLoS Pathog 2015;11:e1005286. [PMID: 26624012 DOI: 10.1371/journal.ppat.1005286] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
135 Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Chandran B. Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells. J Virol 2009;83:4895-911. [PMID: 19279100 DOI: 10.1128/JVI.02498-08] [Cited by in Crossref: 108] [Cited by in F6Publishing: 81] [Article Influence: 8.3] [Reference Citation Analysis]
136 Matsuura H, Kirschner AN, Longnecker R, Jardetzky TS. Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex. Proc Natl Acad Sci U S A 2010;107:22641-6. [PMID: 21149717 DOI: 10.1073/pnas.1011806108] [Cited by in Crossref: 117] [Cited by in F6Publishing: 115] [Article Influence: 9.8] [Reference Citation Analysis]